S

Sonic is an EVM L1 platform that offers developers attractive incentives and powerful infrastructure for DeFi. The chain provides 10,000 TPS and sub-second confirmation times, powering the next generation of decentralized applications. Sonic's Fee Monetization (FeeM) program rewards developers with up to 90% of the fees their apps generate, adapting the Web2 ad-revenue model to a decentralized framework. Developers now directly profit from their app's traffic and user engagement. Furthermore, the Sonic Gateway provides developers and users with seamless access to vast liquidity through a native, secure bridge connected to Ethereum. With a unique fail-safe mechanism, it ensures your assets are protected in all circumstances.

NimiS

KohtNo.140

Turulagi$0.00

Täielikult lahjendatud turukapital$0.00

Turuosa0.0001%

Kauplemismaht/turukapital (24H)0.73%

Ringlev varu2,880,000,000

Maksimaalne varu∞

Koguvaru3,222,625,000

Ringluse määr%

Väljaandmise kuupäev--

Hind, millega vara esmakordselt välja anti--

Kõigi aegade kõrgeim1.0293171074857816,2025-01-04

Madalaim hind0.08891597598153189,2025-10-10

Avalik plokiahelSONIC

TutvustusSonic is an EVM L1 platform that offers developers attractive incentives and powerful infrastructure for DeFi. The chain provides 10,000 TPS and sub-second confirmation times, powering the next generation of decentralized applications. Sonic's Fee Monetization (FeeM) program rewards developers with up to 90% of the fees their apps generate, adapting the Web2 ad-revenue model to a decentralized framework. Developers now directly profit from their app's traffic and user engagement. Furthermore, the Sonic Gateway provides developers and users with seamless access to vast liquidity through a native, secure bridge connected to Ethereum. With a unique fail-safe mechanism, it ensures your assets are protected in all circumstances.

Sektor

Sotsiaalmeedia

• Telegram
• Twitter
• Discord
• Reddit

• Valge raamat
• Ametlik veebisait
• Blokeerige Explorer

etfindex:mc_etfindex_sourceLahtiütlus: Andmed on esitanud cmc ja neid ei tohiks käsitleda investeerimisnõuannetena.